Home
About
Services
Partners
Client Portfolio
News
Contact
Gilead to work with partners to ramp up production of potential coronavirus treatment
April 30, 2020
Trump threatens new tariffs on China as U.S. mulls retaliatory action over virus
April 30, 2020
0
Amgen studying Otezla for coronavirus, looking into other treatments
Published by
Muller&Green
at
April 30, 2020
Categories
RSS
Tags
Amgen Inc on Thursday reported better-than-expected first-quarter results and said it plans to study psoriasis drug Otezla as a potential treatment for COVID-19, the respiratory disease caused by the new coronavirus.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more